ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001609805

Nussbaum Ran

CIK 0001609805 Name as filed on the most recent filing

Filed as Nussbaum Ran (15)

54 transaction lines · from 15 filings · filed 2015-03-31 to 2025-10-17 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

46 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2025-10-15 Keros Therapeutics, Inc.
KROS 		S, Open-market sale 2,284,612 disposed 17.75 40,551,863.00 Form 4, filing 0000921895-25-002765
2025-10-15 Keros Therapeutics, Inc.
KROS 		S, Open-market sale 1,226,412 disposed 17.75 21,768,813.00 Form 4, filing 0000921895-25-002765
2025-10-15 Keros Therapeutics, Inc.
KROS 		S, Open-market sale 1,121,045 disposed 17.75 19,898,548.75 Form 4, filing 0000921895-25-002765
2025-10-15 Keros Therapeutics, Inc.
KROS 		S, Open-market sale 155,262 disposed 17.75 2,755,900.50 Form 4, filing 0000921895-25-002765
2025-09-12 LB Pharmaceuticals Inc
LBRX 		P, Open-market purchase 1,000,000 acquired 15.00 15,000,000.00 Form 4, filing 0001609805-25-000006
2021-05-13 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 2,630,487 acquired 1.35 3,551,157.45 Form 4, filing 0001104659-21-067335
2021-05-13 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 1,422,222 acquired 1.35 1,919,999.70 Form 4, filing 0001104659-21-067335
2021-05-13 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 1,280,624 acquired 1.35 1,728,842.40 Form 4, filing 0001104659-21-067335
2021-05-13 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 592,592 acquired 1.35 799,999.20 Form 4, filing 0001104659-21-067335
2020-11-17 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 26,634 acquired 50.00 1,331,700.00 Form 4, filing 0001209191-20-059411
2020-11-17 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 14,400 acquired 50.00 720,000.00 Form 4, filing 0001209191-20-059411
2020-11-17 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 12,966 acquired 50.00 648,300.00 Form 4, filing 0001209191-20-059411
2020-11-17 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 6,000 acquired 50.00 300,000.00 Form 4, filing 0001209191-20-059411
2020-04-13 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 194,203 acquired 16.00 3,107,248.00 Form 4, filing 0001209191-20-024229
2020-04-13 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 105,000 acquired 16.00 1,680,000.00 Form 4, filing 0001209191-20-024229
2020-04-13 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 94,546 acquired 16.00 1,512,736.00 Form 4, filing 0001209191-20-024229
2020-04-13 Keros Therapeutics, Inc.
KROS 		P, Open-market purchase 43,750 acquired 16.00 700,000.00 Form 4, filing 0001209191-20-024229
2019-06-27 Arqule Inc
ARQL 		P, Open-market purchase 133,548 acquired 9.75 1,302,093.00 Form 4, filing 0001019695-19-000026
2019-06-27 Arqule Inc
ARQL 		P, Open-market purchase 72,205 acquired 9.75 703,998.75 Form 4, filing 0001019695-19-000026
2019-06-27 Arqule Inc
ARQL 		P, Open-market purchase 65,016 acquired 9.75 633,906.00 Form 4, filing 0001019695-19-000026
2019-06-27 Arqule Inc
ARQL 		P, Open-market purchase 36,923 acquired 9.75 359,999.25 Form 4, filing 0001019695-19-000026
2019-06-24 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 86,806 acquired 9.00 781,254.00 Form 4, filing 0001144204-19-032486
2019-06-24 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 46,933 acquired 9.00 422,397.00 Form 4, filing 0001144204-19-032486
2019-06-24 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 42,261 acquired 9.00 380,349.00 Form 4, filing 0001144204-19-032486
2019-06-24 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 24,000 acquired 9.00 216,000.00 Form 4, filing 0001144204-19-032486
2018-07-13 Arqule Inc
ARQL 		P, Open-market purchase 89,676 acquired 5.50 493,218.00 Form 4, filing 0001019695-18-000024
2018-07-13 Arqule Inc
ARQL 		P, Open-market purchase 48,485 acquired 5.50 266,667.50 Form 4, filing 0001019695-18-000024
2018-07-13 Arqule Inc
ARQL 		P, Open-market purchase 43,657 acquired 5.50 240,113.50 Form 4, filing 0001019695-18-000024
2018-05-18 Arqule Inc
ARQL 		P, Open-market purchase 8,611 acquired 3.29 28,330.19 Form 4, filing 0001019695-18-000021
2018-05-18 Arqule Inc
ARQL 		P, Open-market purchase 8,611 acquired 3.29 28,330.19 Form 4, filing 0001019695-18-000020
2018-04-30 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 172,626 acquired 9.75 1,683,103.50 Form 4, filing 0001209191-18-027112
2018-04-30 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 93,333 acquired 9.75 909,996.75 Form 4, filing 0001209191-18-027112
2018-04-30 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 84,041 acquired 9.75 819,399.75 Form 4, filing 0001209191-18-027112
2018-03-22 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 2,959 acquired 8.00 23,672.00 Form 4, filing 0001209191-18-021398
2018-03-22 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 1,600 acquired 8.00 12,800.00 Form 4, filing 0001209191-18-021398
2018-03-22 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 1,441 acquired 8.00 11,528.00 Form 4, filing 0001209191-18-021398
2018-03-21 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 3,255 acquired 7.55 24,575.25 Form 4, filing 0001209191-18-021398
2018-03-21 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 1,760 acquired 7.55 13,288.00 Form 4, filing 0001209191-18-021398
2018-03-21 Eloxx Pharmaceuticals, Inc.
ELOX 		P, Open-market purchase 1,585 acquired 7.55 11,966.75 Form 4, filing 0001209191-18-021398
2017-05-09 Kite Pharma, Inc.
KITE 		P, Open-market purchase 3,520 acquired 69.17 243,478.40 Form 4, filing 0001209191-17-031484
2017-05-09 Kite Pharma, Inc.
KITE 		P, Open-market purchase 2,651 acquired 69.17 183,369.67 Form 4, filing 0001209191-17-031484
2017-05-09 Kite Pharma, Inc.
KITE 		P, Open-market purchase 2,632 acquired 68.94 181,450.08 Form 4, filing 0001209191-17-031484
2017-05-09 Kite Pharma, Inc.
KITE 		P, Open-market purchase 1,029 acquired 69.17 71,175.93 Form 4, filing 0001209191-17-031484
2015-06-02 Kite Pharma, Inc.
KITE 		S, Open-market sale 200,604 disposed 55.27 11,087,383.08 Form 4, filing 0001209191-15-049860
2015-06-02 Kite Pharma, Inc.
KITE 		S, Open-market sale 24,070 disposed 56.08 1,349,845.60 Form 4, filing 0001209191-15-049860
2015-06-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 69,206 disposed 55.05 3,809,790.30 Form 4, filing 0001209191-15-049860
2015-06-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 7,800 disposed 57.38 447,564.00 Form 4, filing 0001209191-15-049860
2015-06-01 Kite Pharma, Inc.
KITE 		S, Open-market sale 3,754 disposed 56.44 211,875.76 Form 4, filing 0001209191-15-049860
2015-03-30 Kite Pharma, Inc.
KITE 		S, Open-market sale 66,948 disposed 59.91 4,011,129.17 Form 4, filing 0001209191-15-030533
2015-03-30 Kite Pharma, Inc.
KITE 		S, Open-market sale 25,560 disposed 59.91 1,531,404.40 Form 4, filing 0001209191-15-030533

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 35
  • Open-market sale 11
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Nussbaum Ran, insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001609805

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.